Search results
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication
WSB Radio· 9 hours agoThe Food and Drug Administration convened a panel of outside experts Tuesday to review the latest...
FDA panel rejects MDMA therapy for treating patients with PTSD
WSB Radio· 1 hour agoAn independent advisory panel of the Food and Drug Administration on Tuesday rejected the use of...
Denali's (DNLI) Candidate Selected for FDA's START Pilot Program
Zacks via Yahoo Finance· 8 hours agoDenali's (DNLI) DNL126, an investigational enzyme replacement therapy, gets selected for the START...
FDA panel votes against MDMA therapy for PTSD, citing muddy data and safety concerns
BioPharma Dive via Yahoo Finance· 7 hours agoA group of independent experts wasn't convinced by clinical trial data from company Lykos...
Flawed, scandalous trials tank FDA expert support for MDMA therapy
Ars Technica· 2 hours agoIn response to the second question, "Do the benefits of midomafetamine with FDA’s proposed risk...
FDA advisers consider MDMA therapy to treat PTSD
WKBT La Crosse· 13 hours agoIt’s the first time the FDA’s advisers have considered a psychedelic drug for medical use. The novel treatment has the potential to transform ...
US expert panel votes against MDMA therapy
BBC via Yahoo News· 27 minutes ago"Each one alone might be OK, but when you pile them on top of each other … there’s just a lot of questions I would have about how effective the treatment...
FDA panel rejects first MDMA treatment amid deep concerns about flawed trials
NBC NEWS· 3 hours agoThe two votes — one for the treatment’s efficacy and one for its safety, by the agency’s...
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication
Pittsburgh Tribune-Review· 9 hours agoThe Food and Drug Administration convened a panel of outside experts Tuesday to review the latest...
FDA advisers consider MDMA therapy to treat PTSD
WKBT La Crosse· 8 hours agoClick here to view this video from News8000.com.
